Jinhe Biotechnology CO.,LTD. — Investor Relations & Filings
Jinhe Biotechnology CO.,LTD. specializes in the research, development, and manufacturing of animal health products and feed additives. The company is a prominent global producer of chlortetracycline (CTC), maintaining extensive production capacity for feed-grade antibiotics. Its diverse product portfolio includes veterinary pharmaceuticals such as salinomycin and monensin, alongside a range of biological products and animal vaccines. Jinhe Biotechnology leverages advanced fermentation technology and integrated research capabilities to provide solutions for the livestock and poultry sectors. The company focuses on improving animal growth performance and disease prevention through standardized production processes and a global distribution network. Its operations span the development of specialized additives and the provision of comprehensive veterinary medical products designed to support large-scale animal husbandry.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于完成工商变更登记的公告 | 2025-07-14 | Chinese | |
| 2025年半年度业绩预告 | 2025-07-13 | Chinese | |
| 关于参加内蒙古辖区上市公司2025年投资者网上集体接待日活动的公告 | 2025-07-09 | Chinese | |
| 关于召开2025年第四次临时股东大会通知的公告 | 2025-07-07 | Chinese | |
| 关于2023年限制性股票激励计划首次授予第二个解除限售期及预留授予第一个解除限售期解除限售条件成就的公告 | 2025-07-07 | Chinese | |
| 监事会关于2023年限制性股票激励计划相关事项的核查意见 | 2025-07-07 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36982777 | 关于完成工商变更登记的公告 | 2025-07-14 | Chinese | ||
| 36982771 | 2025年半年度业绩预告 | 2025-07-13 | Chinese | ||
| 36982764 | 关于参加内蒙古辖区上市公司2025年投资者网上集体接待日活动的公告 | 2025-07-09 | Chinese | ||
| 36982759 | 关于召开2025年第四次临时股东大会通知的公告 | 2025-07-07 | Chinese | ||
| 36982752 | 关于2023年限制性股票激励计划首次授予第二个解除限售期及预留授予第一个解除限售期解除限售条件成就的公告 | 2025-07-07 | Chinese | ||
| 36982743 | 监事会关于2023年限制性股票激励计划相关事项的核查意见 | 2025-07-07 | Chinese | ||
| 36982730 | 第六届监事会第二十二次会议决议公告 | 2025-07-07 | Chinese | ||
| 36982719 | 北京市中伦(上海)律师事务所关于金河生物科技股份有限公司2023年限制性股票激励计划首次授予第二个解除限售期和预留授予第一个解除限售期解除限售条件成就、回购注销部分限制性股票及调整回购价格相关事项的法律意见书 | 2025-07-07 | Chinese | ||
| 36982701 | 关于公司为全资子公司提供担保额度预计的公告 | 2025-07-07 | Chinese | ||
| 36982693 | 关于全资子公司投资建设污水处理扩容及水资源再生利用提标扩建工程项目的公告 | 2025-07-07 | Chinese | ||
| 36982610 | 关于回购注销部分限制性股票及调整回购价格的公告 | 2025-07-07 | Chinese | ||
| 36982602 | 关于增加公司2025年日常关联交易预计额度的公告 | 2025-07-07 | Chinese | ||
| 36982591 | 第六届董事会第二十七次会议决议公告 | 2025-07-07 | Chinese | ||
| 36982582 | 2025年第三次临时股东大会决议的公告 | 2025-06-26 | Chinese | ||
| 36982573 | 关于金河生物科技股份有限公司二零二五年第三次临时股东大会的法律意见书 | 2025-06-26 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Jinhe Biotechnology CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54706/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54706 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54706 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54706 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54706}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jinhe Biotechnology CO.,LTD. (id: 54706)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.